1731.TW

Strong BuyFull HouseFLAG

Maywufa Company Ltd. · Healthcare · Taiwan · $88M · Avg Vol: $59K/d

Full House: Strong business, sensible price, market agrees. The rare full house.

94
StockRank
Get insider-trade alerts
Quality
67
Value
76
Momentum
55
P/E (TTM)
13.8x
peers 15.7x
ROE
9.5%
peers 4.1%
D/E
0.3x
peers 0.1x
Dividend %
5.8%
trailing yield
AI CONVICTION THESIS

Maywufa sells health foods and consumer products in Taiwan, with a reasonable quality score (Q69) but weak momentum (M48) and a marginal consensus trim, and there is no supportive filings evidence. Nothing adverse is known, so the default applies.

The ranks quoted here are from the day it was written; today's Quality, Value and Momentum are the bars above.

ABOUT MAYWUFA COMPANY LTD.

Read

Maywufa Company Ltd. manufactures hair care products and distributes pharmaceuticals and medical devices. The company's competitive moat is driven by its leading domestic brand in hair coloring and personal care, complemented by a stable pharmaceutical distribution business. It operates as a diversified healthcare and consumer defensive player with strong brand loyalty and regulatory expertise.

FINANCIAL SUMMARY (TWD)

Year20212022202320242025CAGRTTM
Revenue1.2B1.3B1.5B1.6B8.4%1.6B
EPS (TWD)1.241.221.271.301.362.4%1.51
Shares132.9M132.9M132.9M132.9M0.0%132.9M
Debt227.0M442.7M673.8M641.8M41.4%639.8M
Equity2.0B2.0B2.1B2.2B2.7%
Op CF147.9M244.3M215.7M223.2M14.7%250.7M
Inv CF36.2M-308.4M-295.9M22.1M
Fin CF-245.5M66.5M74.3M-196.5M
Loading 1Y...
PRICE (1Y)-0.9%
0.650.650.660.660.67Aug 10Aug 31Sep 18
SMA 50SMA 200

Close
$0.6596
RSI (14)
52.6
52W High
$0.6848
From 52W High
1.0%

SCORE BREAKDOWN

Quality
67
ROIC
8.4%65.9
ROE
9.5%68.7
GP/Assets
31.3%66.3
Op. Margin
12.1%68.6
FCF/Assets
6.3%75.4
Piotroski
894.2
Int. Cover
28.6x74.6
D/E Ratio
0.29x41.6
Current Ratio
2.06x40.6
Value
76
P/E (TTM)
13.8x76.8
EV/EBITDA
10.0x69.1
P/FCF
13.6x75.4
P/B
1.3x78.2
P/S
1.7x72.2
Div Yield
5.8%93.9
Momentum
55
52W High %
96%94.8
RS 6M
-35%26.0
SMA 50/200
1.01x58.8
EPS Rev 4W
+1.8%79.8
EPS Rev 12W
-1.3%32.4
EPS Improve
-27%13.7
Q Growth
30%63.7

FUNDAMENTALS

Market Cap
$88M
P/E (Forward)
19.0x
Gross Margin
62.3%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 1731.TW are excluded.

TickerCompanyMkt CapStockRankSignal
1731.TWMaywufa Company Ltd.(you)$88M94Strong Buy
8432.TWOTSH Biopharm Corporation Limited$62M100Strong Buy
1720.TWStandard Chemical & Pharmaceutical Co., Ltd.$351M97Strong Buy
1760.TWPanion & Bf Biotech Inc.$158M76Buy
1707.TWGrape King Bio Ltd$418M95Strong Buy
3705.TWYungShin Global Holding Corporation$471M98Strong Buy
4746.TWFormosa Laboratories, Inc.$188M72Buy
4105.TWOTTY Biopharm Company Limited$612M97Strong Buy
3054.TWLIWANLI Innovation Co., Ltd.$145M53Hold
4127.TWOTien Liang BioTech Co., Ltd.$114M38Hold

Peer medians: ROE 4.1% · P/E 15.7x · Gross margin 41.6%

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

Maywufa Company Ltd. (1731.TW): Stock Score Summary

Maywufa Company Ltd. (1731.TW) has a MoatMap StockRank of 94/100 based on Quality (67/100), Value (76/100), and Momentum (55/100) factor scores. The current signal is STRONG BUY. Maywufa sells health foods and consumer products in Taiwan, with a reasonable quality score (Q69) but weak momentum (M48) and a marginal consensus trim, and there is no supportive filings evidence. Nothing adverse is known, so the default applies.

Maywufa Company Ltd. manufactures hair care products and distributes pharmaceuticals and medical devices. The company's competitive moat is driven by its leading domestic brand in hair coloring and personal care, complemented by a stable pharmaceutical distribution business. It operates as a diversified healthcare and consumer defensive player with strong brand loyalty and regulatory expertise.

Key Financial Metrics

Price$0.66
Market Cap$88M
P/E (TTM)13.84
P/E (Forward)19.00
Price/Book1.27
Return on Equity9.5%
Return on Invested Capital8.4%
Debt/Equity0.29x
Gross Margin62.3%
Operating Margin12.1%
Revenue Growth7.3%
Dividend Yield5.8%
Free Cash Flow$6M

Maywufa Company Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (Taiwan).

Frequently Asked Questions

What is Maywufa Company Ltd.’s (1731.TW) StockRank?
MoatMap’s StockRank for Maywufa Company Ltd. (1731.TW) is 94/100, with a Strong Buy signal. It is a composite of Quality (67), Value (76), and Momentum (55) factor ranks across MoatMap’s universe of 25,000+ stocks.
Does Maywufa Company Ltd. have an economic moat?
Maywufa Company Ltd. (1731.TW) has a Quality factor score of 67/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Maywufa Company Ltd. a buy, hold, or sell?
MoatMap’s current signal for Maywufa Company Ltd. (1731.TW) is Strong Buy, based on a StockRank of 94/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.
What sector is Maywufa Company Ltd. in?
Maywufa Company Ltd. (1731.TW) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (Taiwan).